Frequency Characterization of Blood Glucose Dynamics

Examples of the frequency range of blood glucose dynamics of normal subjects and subjects with diabetes are reported here, based on data from the literature. The frequency band edge was determined from suitable, frequently sampled blood glucose recordings using two methods: frequency domain estimation and signal reconstruction. The respective maximum acceptable sampling intervals, or Nyquist sampling periods (NSP), required to accurately represent blood glucose dynamics were calculated. Preliminary results based on the limited data available in the literature indicate that although blood glucose NSP values are higher in most diabetic subjects, values in some diabetic subjects are indistinguishable from those of normal subjects. High fidelity monitoring sufficient to follow the intrinsic blood glucose dynamics of all diabetic subjects requires a NSP of ~ 10 min, corresponding to a continuous frequency band edge of ~ 1 × 10−3 Hz. This analysis provides key information for the design of clinical studies that include blood glucose dynamics and for the design of new glucose monitoring systems. © 2003 Biomedical Engineering Society.

[1]  W. F. Taylor,et al.  Continuous blood glucose analysis in ambulatory fed subjects. II. Effects of anticoagulation with heparin. , 1969, Mayo Clinic proceedings.

[2]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[3]  W Kerner,et al.  On line continuous monitoring of subcutaneous tissue glucose is feasible by combining portable glucosensor with microdialysis. , 1993, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[4]  Alan V. Oppenheim,et al.  Discrete-Time Signal Pro-cessing , 1989 .

[5]  G D Molnar,et al.  Urine glucose analyses during continuous. , 1972, JAMA.

[6]  D. Gough,et al.  Is blood glucose predictable from previous values? A solicitation for data. , 1999, Diabetes.

[7]  K Ito,et al.  Clinical usefulness of artificial endocrine pancreas "Biostator" in management of unstable diabetics. , 1983, The Tohoku journal of experimental medicine.

[8]  W. F. Taylor,et al.  Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability , 1970, Diabetes.

[9]  P. Gallop,et al.  Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus. , 1977, The Journal of clinical endocrinology and metabolism.

[10]  K. Moxness,et al.  Continuous blood glucose analysis in ambulatory fed subjects. I. General methodology. , 1968, Mayo Clinic proceedings.

[11]  P. Reichard,et al.  The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. , 1993, The New England journal of medicine.

[12]  Ukpds,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes , 2002 .

[13]  W. Clarke,et al.  Studies with a pancreatic beta cell simulator in the third trimester of pregnancies complicated by diabetes. , 1978, American journal of obstetrics and gynecology.

[14]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[15]  Benchmark data from the literature for evaluation of new glucose sensing technologies. , 2001, Diabetes technology & therapeutics.